SARS-CoV-2 Disguise Study
NCT04395794 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2020-05-20
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants. The aim is to test the percentage and increase of the SARS-CoV-2 positive carriers among asymptomatic medical employees in high-volume cardiovascular center in routine clinical practice.
Conditions
- Sars-CoV2
Interventions
- DIAGNOSTIC_TEST
-
SARS-CoV-2-test
Nasopharyngeal and oropharyngeal testing for SARS-CoV-2
- OTHER
-
SARS-CoV-2 questionnaire survey
Questionnaire regarding SARS-CoV-2 symptoms and contact with COVID patients
Sponsors & Collaborators
-
Meshalkin Research Institute of Pathology of Circulation
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-07
- Primary Completion
- 2020-08-31
- Completion
- 2020-11-30
Countries
- Russia
Study Locations
More Related Trials
-
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
NCT06334731 ·Status: COMPLETED
-
Evaluation of Antibody Tests for COVID-19
NCT04360954 ·Status: COMPLETED
-
Microbial Infection and AMR in Hospitalized Patients With Covid 19
NCT04479982 ·Status: UNKNOWN
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA
-
Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine
NCT06144333 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.
NCT04805892 ·Status: COMPLETED ·Phase: NA
-
Dysbiosis & Long COVID
NCT06825819 ·Status: RECRUITING
-
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers
NCT04681001 ·Status: COMPLETED ·Phase: NA
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
NCT04523831 ·Status: COMPLETED ·Phase: PHASE3
-
CORE Study COVID-19
NCT04531202 ·Status: UNKNOWN
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
NCT04358809 ·Status: UNKNOWN ·Phase: PHASE3
-
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
NCT04345315 ·Status: UNKNOWN
-
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers
NCT04461379 ·Status: UNKNOWN ·Phase: PHASE3
-
Characteristics of COVID-19 Patients in Kazakhstan in Early 2020
NCT04627194 ·Status: UNKNOWN
-
COVID-19 Vaccination AZV 2021-2023
NCT05589233 ·Status: COMPLETED
-
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.
NCT04402827 ·Status: COMPLETED
-
Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory.
NCT05067920 ·Status: UNKNOWN
-
Immune Response and Risk of Serious Infection to SARS-Cov2
NCT04410432 ·Status: COMPLETED
-
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
NCT04369794 ·Status: COMPLETED ·Phase: PHASE4
-
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
NCT04479488 ·Status: COMPLETED
-
Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 Patients
NCT05338736 ·Status: COMPLETED
-
Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
NCT05664919 ·Status: UNKNOWN ·Phase: NA